In hepatocellular carcinoma, anoikis resistance of hepatoma cells has been determined to require PAK1 activity,23 and CAV1 could also confer resistance of hepatoma cells to anoikis by activating the IGF‐1 pathway.24 Here, CAV1 is linked to hepatocellular carcinoma.